Gritstone bio Announces Presentations Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 at ECCMID 2023
EMERYVILLE, Calif., April 04, 2023 -- Gritstone bio, Inc. , a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced multiple presentations... | April 4, 2023